SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

EVERLERT INC NEW (OTCMKTS:EVLI) is off to a strong start to its second quarter with considerable milestones being recorded by its entertainment and consulting segments. Mark Blankenship, the President and CEO, said that the company is projecting the second quarter to be a breakthrough quarter.

The expectations

The projects are expected to generate revenues to support the operations as well as growth goals. Now that Everlert have concluded the first quarter and left the postage industry, there is a new starting point. It is the main parameter from where the financial performance of the new segments can be identified and tracked in the future financial statements.

The focus

Everlert is focusing on development of its Suge Knight App in conjunction with Rap Mogul Suge Knight and its JV associate, Gleopoint Mobility. Suge Knight has strong online following and prominence, and therefore the Company is confident that the app will be a strong revenue source in the coming quarters. Also, with the highly awaited Canelo Alvarez versus James Kirkland televised fight less than one month away on May 9, 2015 the Company is increasing its involvement in advancing some of the hallmark products covered in its extensive Intellectual Property deal with Boxer James Kirkland.

The plans

Everlert is intends to enter into the growing Electronic Cigarette market, where it plans on ‘private labeling’ electronic cigarette for celebrities. Moreover, it is formulating a celebrity supported private label Electronic Cigar. In addition, the company has sent Darin Shaw, in-house entertainment attorney, on a trip to Seoul to meet with topmost entertainment executives. Korea has evolved a burgeoning economy in the last decade, particularly in the entertainment sector.

In last trading session, the stock price of Everlert declined more than 42%to close the trading session at $0.0260. The sharp decline came at a share volume of 2.24 million compared to average volume of 22,902.